Literature DB >> 2438808

Rapid diagnosis and characterization of equid herpesvirus 1 using monoclonal antibodies.

N Edington, C G Bridges, S C Broad.   

Abstract

Twelve monoclonal antibodies (Mabs) were produced against the attenuated RACH subtype 1 strain of Equid herpesvirus 1. Nine were subtype specific by immunofluorescence or immunoperoxidase, while the other three were against epitopes common to both subtypes. Use of these Mabs allowed isolates to be rapidly and easily subtyped. Immunoblotting indicated that the subtype common Mabs were against viral proteins of MW 140 K and 90 K (VP 9 and 14), while the subtype-specific Mabs were against the glycosylated VP 2 (MW greater than 240 K), and also against VP 12 (MW 110 K) and VP 15 (MW 88 K). Membrane, cytoplasmic, or particulate nuclear patterns of fluorescence were characteristic for each of these proteins. None of the Mabs had neutralising activity but those directed against VP 2 restricted plaque size.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438808

Source DB:  PubMed          Journal:  Tierarztl Prax Suppl        ISSN: 0930-6447


  4 in total

1.  The highly O-glycosylated glycoprotein gp2 of equine herpesvirus 1 is encoded by gene 71.

Authors:  J E Wellington; G P Allen; A A Gooley; D N Love; N H Packer; J X Yan; J M Whalley
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

2.  Evidence for involvement of equine herpesvirus 1 glycoprotein B in cell-cell fusion.

Authors:  J E Wellington; D N Love; J M Whalley
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  A type-specific conformational epitope on the nucleocapsid of equid herpesvirus-1 and its use in diagnosis.

Authors:  A van de Moer; M Rice; C R Wilks
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Detection of antibodies against equine herpesvirus types 1 and 4 by using recombinant protein derived from an immunodominant region of glycoprotein B.

Authors:  R Sinclair; M M Binns; E D Chirnside; J A Mumford
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.